BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 6210188)

  • 41. [CA 19-9 and cancer of the pancreas. Critical review of the literature].
    Delcourt A
    Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of tumor markers in the diagnosis and management of gastrointestinal cancer.
    Heptner G; Domschke S; Domschke W
    Hepatogastroenterology; 1986 Aug; 33(4):140-4. PubMed ID: 2428718
    [No Abstract]   [Full Text] [Related]  

  • 43. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
    Schmiegel WH; Kalthoff H
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
    [No Abstract]   [Full Text] [Related]  

  • 44. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
    Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
    Klöppel G
    Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 47. [Value of CEA and serum glycoprotein findings in tumor diagnosis].
    Wintzer G; Koch O; Uhlenbruck G
    Internist (Berl); 1980 Apr; 21(4):181-8. PubMed ID: 6998906
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical aspects of the CEA test.
    Laurence JR; Neville AM
    Bull Cancer; 1976; 63(4):473-81. PubMed ID: 1021177
    [No Abstract]   [Full Text] [Related]  

  • 49. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tumor markers in digestive oncology: present status of the topic and prospects for the future].
    Desaive C
    Rev Med Liege; 1987 Nov; 42(22):881-7. PubMed ID: 2447625
    [No Abstract]   [Full Text] [Related]  

  • 51. [Carcinoembryonic antigen in gastrointestinal neoplasms].
    Auer IO
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1101-4. PubMed ID: 330129
    [No Abstract]   [Full Text] [Related]  

  • 52. [The informativeness of immunoenzyme analysis in cancer of the gastrointestinal tract].
    Ial'chenko NA; Lagutin VD
    Lab Delo; 1991; (11):48-50. PubMed ID: 1722850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of a serum pancreatic tumor marker: the carbohydrate antigen C.A. 19-9].
    Vincent D; Venot J; Catanzano G; Clément MN; Piquet MF; Veyriras E; Beck C
    Ann Med Interne (Paris); 1985; 136(2):142-4. PubMed ID: 3865571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A promising tumor marker CA 19-9 for pancreatic carcinoma: comparison with CEA and elastase 1].
    Sakahara H; Endo K; Nakajima K; Nakashima T; Ohta H; Torizuka K; Naito A; Suzuki T
    Kaku Igaku; 1985 Jan; 22(1):115-8. PubMed ID: 3858565
    [No Abstract]   [Full Text] [Related]  

  • 56. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of carbohydrate antigens 19-9 and 12-5 in patients with pancreatic cancer.
    Pasquali C; Sperti C; D'Andrea AA; Bonadimani B; Del Favero G; Petrin P; Pedrazzoli S
    Pancreas; 1987; 2(1):34-7. PubMed ID: 3472197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoembryonic antigen in benign and malignant diseases of the digestive tract.
    Zamcheck N; Moore TL; Dhar P; Kupchik HZ; Sorokin JJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():433-9. PubMed ID: 4659055
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antigens in the blood serum in pancreatic cancer].
    Vel'bri SK
    Vopr Onkol; 1979; 25(11):28-31. PubMed ID: 516561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.